Product Name:tert-butyl N-(4-methylpiperidin-4-yl)carbamate

IUPAC Name:tert-butyl N-(4-methylpiperidin-4-yl)carbamate

CAS:163271-08-7
Molecular Formula:C11H22N2O2
Purity:95%+
Catalog Number:CM103826
Molecular Weight:214.31

Packing Unit Available Stock Price($) Quantity
CM103826-10g in stock ŴŴ
CM103826-25g in stock ưɅƀ
CM103826-100g in stock ȁƀɅ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:163271-08-7
Molecular Formula:C11H22N2O2
Melting Point:-
Smiles Code:CC(C)(C)OC(=O)NC1(C)CCNCC1
Density:
Catalog Number:CM103826
Molecular Weight:214.31
Boiling Point:308°C at 760 mmHg
MDL No:MFCD08703167
Storage:Store at 2-8°C.

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

Column Infos

Darovasertib
The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Darovasertib, a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma”. Uveal melanoma (UM) is the most common primary intraocular malignancy. About half of primary uveal melanoma tumors metastasize but with no standard treatment. Most patients with metastatic uveal melanoma have been found to have mutations in GNAQ or GNA11, that are associated with consistent activation of the protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) pathways.
IDEAYA's Darovasertib (IDE196) is a potent, selective small molecule inhibitor of PKC which stops activating PKC/MEK pathway. Darovasertib is under Phase 2 expansion and Phase 3 registrational trial with Crizotinib in GNAQ/11 metastatic cutaneous melanoma.

Related Products